PERCEPTIVE ADVISORS LLC Q2 2016 Filing
Filed August 11, 2016
Portfolio Value
$1.4T
Holdings
169
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (169 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SRPTSarepta Therapeutics Inc | 8,598,500 | $164.0B | 11.37% | Put |
| 2 | NBIXNEUROCRINE BIOSCIENCES INC | 2,797,967 | $127.2B | 8.82% | |
| 3 | —TESARO INC | 1,193,615 | $100.3B | 6.95% | Put |
| 4 | AM6AMICUS | 15,239,444 | $83.2B | 5.77% | |
| 5 | SRPTSAREPTA THERAPEUTICS INC | 3,767,316 | $71.8B | 4.98% | |
| 6 | —Retrophin Inc | 3,279,380 | $58.4B | 4.05% | |
| 7 | —MEDIVATION INC | 760,000 | $45.8B | 3.18% | |
| 8 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 2,207,668 | $36.6B | 2.54% | |
| 9 | —VERSARTIS INC | 2,835,754 | $31.4B | 2.17% | |
| 10 | —NXSTAGE MEDICAL INC | 1,382,410 | $30.0B | 2.08% | |
| 11 | —LION BIOTECHNOLOGIES INC | 3,611,976 | $29.3B | 2.03% | |
| 12 | XNCRXENCOR INC | 1,529,574 | $29.0B | 2.01% | |
| 13 | XBISTREETTRACKS SPDR BIOTEC ETF | 500,000 | $27.0B | 1.87% | Put |
| 14 | NVROEURNEVRO CORP | 365,229 | $26.9B | 1.87% | |
| 15 | —CELATOR PHARMACEUTICALS INC | 838,400 | $25.3B | 1.75% | |
| 16 | —LA JOLLA PHARMACEUTICAL CO | 1,332,815 | $21.3B | 1.48% | |
| 17 | XLRNACCELERON | 603,036 | $20.5B | 1.42% | |
| 18 | —ST JUDE MEDICAL | 233,000 | $18.2B | 1.26% | |
| 19 | —DBV TECHNOLOGIES S A | 546,696 | $17.8B | 1.24% | |
| 20 | —QUOTIENT LTD | 2,249,067 | $17.4B | 1.21% | |
| 21 | EVHEVOLENT HEALTH INC | 873,064 | $16.8B | 1.16% | |
| 22 | —ACELRX PHARMA | 5,995,760 | $16.1B | 1.12% | |
| 23 | —DERMIRA INC | 462,000 | $13.5B | 0.94% | |
| 24 | —VBI VACCINES INC | 3,058,433 | $12.1B | 0.84% | |
| 25 | —DEPOMED INC | 600,000 | $11.7B | 0.81% | |
| 26 | EGRXEAGLE PHARMACEUTICALS INC | 300,000 | $11.6B | 0.81% | |
| 27 | VRTXVERTEX PHARMACEUTICALS INC | 130,000 | $11.2B | 0.78% | |
| 28 | ALDXALDEYRA | 1,940,458 | $11.0B | 0.77% | |
| 29 | WVEWAVE LIFE SCIENCES LTD | 522,595 | $10.8B | 0.75% | |
| 30 | —CAPITAL SR LIVING CORP | 586,136 | $10.4B | 0.72% | |
| 31 | HEDJWISDOMTREE EUROPE HEDGED EQU | 200,000 | $10.1B | 0.70% | Put |
| 32 | —ALDER BIOPHARMACEUTICALS INC | 400,000 | $10.0B | 0.69% | |
| 33 | DC4DEXCOM INC | 125,174 | $9.9B | 0.69% | |
| 34 | QUREUNIQURE NV | 1,342,093 | $9.9B | 0.69% | |
| 35 | TEVATEVA PHARMACEUTICAL INDS LTD | 196,000 | $9.8B | 0.68% | |
| 36 | CRBPEURCORBUS PHARMACEUTICALS HLDGS | 3,200,000 | $9.6B | 0.66% | |
| 37 | 2L9BLUEPRINT MEDICINES CORP | 464,404 | $9.4B | 0.65% | |
| 38 | —APPLIED GENETIC TECHNOL CORP | 658,851 | $9.3B | 0.65% | |
| 39 | RGNXREGENXBIO INC | 1,099,213 | $8.8B | 0.61% | |
| 40 | NERVGBPMINERVA NEUROSCIENCES INC | 810,537 | $8.3B | 0.57% | |
| 41 | —CIDARA THERAPEUTICS INC | 792,857 | $8.2B | 0.57% | |
| 42 | —ANI PHARMACEUTICALS INC | 7,500,000 | $8.1B | 0.56% | |
| 43 | —PFENEX INC | 960,877 | $8.0B | 0.56% | |
| 44 | CTMXCYTOMX THERAPEUTICS INC | 742,021 | $7.6B | 0.53% | |
| 45 | —pSivida Corp | 2,665,000 | $7.5B | 0.52% | |
| 46 | —FIVE PRIME THERAPEUTICS INC | 169,439 | $7.0B | 0.49% | |
| 47 | —NEPTUNE TECHNOLOGIES BIORESO | 6,750,444 | $6.9B | 0.48% | |
| 48 | AKBAAKEBIA THERAPEUTICS INC | 893,600 | $6.7B | 0.46% | |
| 49 | SELBUSDSELECTA BIOSCIENCES INC | 450,000 | $6.3B | 0.44% | |
| 50 | —MYOKARDIA INC | 502,894 | $6.2B | 0.43% | |
| 51 | —AXOVANT SCIENCES LTD | 485,000 | $6.2B | 0.43% | |
| 52 | —ZYNERBA PHARMACEUTICALS INC | 849,350 | $5.8B | 0.40% | |
| 53 | —FORWARD PHARMA A/S | 311,400 | $5.7B | 0.39% | |
| 54 | —ACADIA PHARMACEUTICALS INC | 165,240 | $5.4B | 0.37% | |
| 55 | SUPNSUPERNUS PHARMACEUTICALS INC | 250,000 | $5.1B | 0.35% | |
| 56 | —FOAMIX PHARMACEUTICALS LTD | 795,000 | $5.0B | 0.35% | |
| 57 | CLLSCELLECTIS S A | 183,507 | $4.9B | 0.34% | |
| 58 | —ALCOBRA LTD | 1,028,272 | $4.6B | 0.32% | |
| 59 | —ANTHERA PHARMACEUTICALS INC | 1,492,156 | $4.6B | 0.32% | |
| 60 | —NEOS THERAPEUTICS INC | 626,876 | $4.6B | 0.32% | |
| 61 | —ONCOBIOLOGICS INC | 1,312,763 | $4.5B | 0.31% | |
| 62 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 634,808 | $4.5B | 0.31% | |
| 63 | —ASSEMBLY BIOSCIENCES INC | 795,000 | $4.4B | 0.31% | |
| 64 | —NEURODERM LTD | 270,000 | $4.4B | 0.30% | |
| 65 | —Abeona Therapeutics Inc | 1,762,881 | $4.2B | 0.29% | |
| 66 | —AGILE THERAPEUTICS INC | 514,288 | $3.9B | 0.27% | |
| 67 | BSFAANI PHARMACEUTICALS INC | 67,161 | $3.7B | 0.26% | |
| 68 | —TOKAI PHARMACEUTICALS INC | 661,041 | $3.6B | 0.25% | |
| 69 | —GENVEC INC | 606,644 | $3.4B | 0.24% | |
| 70 | —Cascadian Therapeutics Inc | 3,414,121 | $3.2B | 0.22% | |
| 71 | —PROTEOSTASIS THERAPEUTICS IN | 250,000 | $3.0B | 0.21% | |
| 72 | —AVEO PHARMACEUTICALS INC | 3,108,808 | $3.0B | 0.21% | |
| 73 | —INNOCOLL HLDGS PLC | 560,000 | $2.8B | 0.19% | |
| 74 | —CEMPRA INC | 170,000 | $2.8B | 0.19% | |
| 75 | —ARDELYX INC | 315,955 | $2.8B | 0.19% | |
| 76 | XENEXENON PHARMACEUTICALS INC | 432,800 | $2.6B | 0.18% | |
| 77 | —ADMA BIOLOGICS INC | 398,394 | $2.4B | 0.16% | |
| 78 | —IGNYTA INC | 435,260 | $2.4B | 0.16% | |
| 79 | ISIIonis Pharmaceuticals Ord Shs | 100,000 | $2.3B | 0.16% | Put |
| 80 | —PROTEON THERAPEUTICS INC | 275,000 | $2.2B | 0.15% | |
| 81 | —MGC DIAGNOSTICS CORP | 336,287 | $2.2B | 0.15% | |
| 82 | —ALLIQUA BIOMEDICAL INC | 1,921,951 | $2.2B | 0.15% | |
| 83 | —PROGENICS PHARMACEUTICALS | 500,000 | $2.1B | 0.15% | Put |
| 84 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 104,920 | $2.1B | 0.14% | |
| 85 | —RELYPSA INC | 100,000 | $1.9B | 0.13% | Put |
| 86 | —AFFIMED N V | 734,301 | $1.8B | 0.13% | |
| 87 | —LIPOCINE INC | 584,400 | $1.8B | 0.12% | Put |
| 88 | —DERMA SCIENCES INC | 432,884 | $1.7B | 0.12% | |
| 89 | —MEDGENICS INC | 300,000 | $1.7B | 0.12% | |
| 90 | —ARATANA THERAPEUTICS INC | 256,500 | $1.6B | 0.11% | |
| 91 | —ABIOMED INC | 14,700 | $1.6B | 0.11% | |
| 92 | —CHINA BIOLOGIC PRODS INC | 14,000 | $1.5B | 0.10% | |
| 93 | VCELVERICEL CORP | 557,342 | $1.3B | 0.09% | |
| 94 | GMEDGLOBUS MED INC | 50,000 | $1.2B | 0.08% | |
| 95 | —ARNO THERAPEUTIC INC | 3,463,292 | $1.1B | 0.07% | |
| 96 | —ABEONA THERAPEUTICS INC | 1,259,636 | $1.1B | 0.07% | |
| 97 | BCLIEURBRAINSTROM CELL THERAPEUTICS | 400,000 | $964.0M | 0.07% | |
| 98 | —PHASERX INC | 200,000 | $852.0M | 0.06% | |
| 99 | CSBRCHAMPIONS ONCOLOGY INC | 372,597 | $801.0M | 0.06% | |
| 100 | LXRXLexicon Pharmaceuticals Inc | 50,000 | $718.0M | 0.05% |
Page 1 of 2Next